Task: Answer the multiple-choice question.
Query: Which drug exhibits a -4.603% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. COc1cccc(N2CCN(CC(=O)Nc3ccccc3C(=O)NCCc3ccccc3)CC2)c1
b. C(=C/c1ccccc1)\CNn1cnnc1
c. COc1cc2c(cc1OC)CN(C(=S)Nc1cccc(Cl)c1C)CC2
Answer: c. COc1cc2c(cc1OC)CN(C(=S)Nc1cccc(Cl)c1C)CC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cc2c(cc1OC)CN(C(=S)Nc1cccc(Cl)c1C)CC2
COc1cc2c(cc1OC)CN(C(=S)Nc1cccc(Cl)c1C)CC2
N-(3-chloro-2-methylphenyl)-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-2-carbothioamide